Thermo Fisher Scientific Inc. (TMO)

Common-Size Statement of Financial Position, Liabilities and Stockholders’ Equity
Quarterly Data

Difficulty: Beginner

Thermo Fisher Scientific Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity (quarterly data)

		Mar 30, 2019		Dec 31, 2018		Sep 29, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jul 1, 2017		Apr 1, 2017		Dec 31, 2016		Oct 1, 2016		Jul 2, 2016		Apr 2, 2016		Dec 31, 2015		Sep 26, 2015		Jun 27, 2015		Mar 28, 2015		Dec 31, 2014		Sep 27, 2014		Jun 28, 2014		Mar 29, 2014
	Short-term obligations and current maturities of long-term obligations
	Accounts payable
	Accrued payroll and employee benefits
	Contract liabilities
	Deferred revenue
	Other accrued expenses
	Current liabilities
	Deferred income taxes
	Other long-term liabilities
	Long-term obligations, excluding current maturities
	Long-term liabilities
	Total liabilities
	Preferred stock, $100 par value; none issued
	Common stock, $1 par value
	Capital in excess of par value
	Retained earnings
	Treasury stock at cost
	Accumulated other comprehensive items
	Shareholders’ equity
	Total liabilities and shareholders’ equity

Item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Thermo Fisher Scientific Inc.’s current liabilities as a percentage of total liabilities and shareholders’ equity increased from Q3 2018 to Q4 2018 but then slightly declined from Q4 2018 to Q1 2019.
Long-term liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Thermo Fisher Scientific Inc.’s long-term liabilities as a percentage of total liabilities and shareholders’ equity declined from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Thermo Fisher Scientific Inc.’s total liabilities as a percentage of total liabilities and shareholders’ equity declined from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.
Shareholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Thermo Fisher Scientific Inc.’s shareholders’ equity as a percentage of total liabilities and shareholders’ equity increased from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

	Thermo Fisher Scientific Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Long-term Trends
Analysis
Financial Reporting Quality

Thermo Fisher Scientific Inc. (TMO)

Common-Size Statement of Financial Position, Liabilities and Stockholders’ EquityQuarterly Data

Common-Size Statement of Financial Position, Liabilities and Stockholders’ Equity
Quarterly Data